Autumn Glory Partners, LLC Abb Vie Inc. Transaction History

Autumn Glory Partners, LLC

$256 Million
Q3 2024

A detailed history of Autumn Glory Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Autumn Glory Partners, LLC holds 12,488 shares of ABBV stock, worth $2.14 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

12,488

Previous 9,585 30.29%

Holding current value

$2.14 Million

Previous $1.64 Million 50.0%

% of portfolio

0.96%

Previous 0.84%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $475,627 - $578,654	2,903 Added 30.29%	12,488 $2.47 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $95,969 - $112,071	620 Added 6.92%	9,585 $1.64 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $151,029 - $172,084	-945 Reduced 9.54%	8,965 $1.63 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $6,880 - $7,748	50 Added 0.51%	9,910 $1.54 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $11,087 - $12,835	-83 Reduced 0.83%	9,860 $1.47 Million
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $470,277 - $585,230	3,549 Added 55.51%	9,943 $1.34 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $3.67 Million - $4.22 Million	-25,359 Reduced 79.86%	6,394 $1.02 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $2.61 Million - $3.13 Million	18,843 Added 145.96%	31,753 $5.13 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $415,514 - $476,567	-3,096 Reduced 19.34%	12,910 $1.73 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $362,215 - $460,494	2,632 Added 19.68%	16,006 $2.45 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $516,701 - $641,081	-3,915 Reduced 22.64%	13,374 $2.17 Million
Q4 2021 Feb 16, 2022	BUY	$107.43 - $135.93 $1.86 Million - $2.35 Million	17,289 New	17,289 $2.34 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Autumn Glory Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autumn Glory Partners, LLC with notifications on news.

Account

Autumn Glory Partners, LLC Abb Vie Inc. Transaction History